Results 21 to 30 of about 5,552,271 (346)

Fathers in the spotlight: parental burden and the effectiveness of a parental skills training for anorexia nervosa in mother–father dyads

open access: yesEating and Weight Disorders, 2023
Purpose Research on the engagement of fathers in the treatment of childhood psychiatric disorders is scarce. This study aims to investigate differences between mothers and fathers of adolescents with anorexia nervosa regarding parental burden and ...
Michael Zeiler   +10 more
doaj   +1 more source

Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder

open access: yesJAMA psychiatry, 2020
This randomized clinical trial examines the efficacy of psilocybin as an adjunct to psychotherapy and other treatments for major depressive disorder.
Alan K. Davis   +7 more
semanticscholar   +1 more source

Electrolyte Disorders

open access: yesClinics in Perinatology, 2014
Electrolyte disorders can result in life-threatening complications. The kidneys are tasked with maintaining electrolyte homoeostasis, yet the low glomerular filtration rate of neonatal kidneys, tubular immaturity, and high extrarenal fluid losses contribute to increased occurrence of electrolyte disorders in neonates.
Bockenhauer, D, Zieg, J
openaire   +3 more sources

Awaiting accurate scientific evidence: Progression or “profiles” in bipolar disorder?

open access: yesInternational Journal of Bipolar Disorders, 2017
This letter is written in response to a review recently published in the journal. The aim is to highlight a potential methodological limitation common to many studies comparing bipolar patients with few previous episodes versus those with multiple ...
Diego J. Martino   +2 more
doaj   +1 more source

Secondary outcomes and qualitative findings of an open-label feasibility trial of lisdexamfetamine dimesylate for adults with bulimia nervosa

open access: yesJournal of Eating Disorders, 2023
Background There is emerging evidence that stimulants warrant further investigation as a treatment for bulimia nervosa (BN) including a recent open-label feasibility trial examining the use of lisdexamfetamine dimestylate (LDX) for BN. The current report
Laura Dixon   +10 more
doaj   +1 more source

Do we need to redefine the advanced stage in Parkinson’s disease?

open access: yesRevista Mexicana de Neurociencia, 2021
Identifying the advanced stage in Parkinson’s disease (PD) is crucial for shifting from conventional to device-aided therapies. The criteria to define the onset of advanced PD have been based on lengthy and disabling daily off-times, troublesome ...
Ángel Sesar   +3 more
doaj   +1 more source

Neurotic “disorders” or “disorder”?

open access: yesPsychiatria Polska, 2019
Cel pracysprawdzenie zasadności przekonania o istnieniu wielu „zaburzeń” nerwicowych.MetodaAnalizy taksonomiczne metodami pojedynczego wiązania, średnich połączeń i metodą Warda oraz grupowanie metodą k-średnich. Podstawowy materiał badawczy stanowiły kwestionariusze objawowe „O”, w których badani opisywali występowanie i nasilenie 135 dolegliwości i ...
openaire   +2 more sources

Home-Based Titration with Duodenal Infusion of Levodopa-Carbidopa Intestinal Gel in People with Parkinson’s Disease: An Observational Feasibility Study

open access: yesParkinson's Disease
Background. Testing and titration of the right levodopa equivalent dose are usually performed during a hospital admission. However, optimal dose titration in people with Parkinson’s disease (PwPs) may depend on home environment, emotional stress, and ...
Trine Hørmann Thomsen   +10 more
doaj   +1 more source

Cerebrospinal Fluid Liquid Biopsy Enables Targeted Therapy Without Tissue Diagnosis in Pediatric Low‐Grade Gliomas With BRAF V600E Mutation

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT We present two pediatric cases of pediatric low‐grade gliomas (PLGG) with BRAF V600E mutations diagnosed and monitored using cerebrospinal fluid (CSF) liquid biopsy analyzed via digital droplet PCR (ddPCR), without tissue biopsy. Both patients were treated with dabrafenib and trametinib and monitored through clinical assessments, magnetic ...
Hannah Sultan   +5 more
wiley   +1 more source

Lessons from the National institutes of health innovation corps program: defining barriers to developing and commercializing novel solutions for persons with opioid use disorder

open access: yesAddiction Science & Clinical Practice
Background Translating innovative research advancements into commercially viable medical interventions presents well-known challenges. However, there is limited understanding of how specific patient, clinical, social, and legal complexities have further ...
Matthew P. Heshmatipour   +9 more
doaj   +1 more source

Home - About - Disclaimer - Privacy